Oral GLP-1 receptor agonists for the treatment of obesity: ATTAINing metabolic benefits to find the OASIS
Abstract
1. Obesity has emerged as a major, public health concern, which also contributes to the development of a plethora of serious obesity-related complications and diseases (ORCDs) [1]. In the fight aga...
Fields of Study & Subjects
Pharmacology and Obesity Treatment
Diabetes Treatment and Management
Regulation of Appetite and Obesity
Publication details
- Journal / source
- Expert Review of Endocrinology & Metabolism
- Volume
- 21
- Issue
- 2
- Pages
- 107–109
- Publication date
- 17 February 2026
- Language
- EN